Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ATHERSYS, INC / NEW | Financial_Report.xls |
| EX-32.1 - EX-32.1 - ATHERSYS, INC / NEW | d284897dex321.htm |
| EX-31.2 - EX-31.2 - ATHERSYS, INC / NEW | d284897dex312.htm |
| 10-K - FORM 10-K - ATHERSYS, INC / NEW | d284897d10k.htm |
| EX-24.1 - EX-24.1 - ATHERSYS, INC / NEW | d284897dex241.htm |
| EX-23.1 - EX-23.1 - ATHERSYS, INC / NEW | d284897dex231.htm |
| EX-31.1 - EX-31.1 - ATHERSYS, INC / NEW | d284897dex311.htm |
| EX-10.36 - EX-10.36 - ATHERSYS, INC / NEW | d284897dex1036.htm |
EXHIBIT 21.1
SUBSIDIARIES OF ATHERSYS, INC.
| Name of Subsidiary |
Jurisdiction | |
| ABT Holding Company (formerly Athersys, Inc.) |
Delaware | |
| Advanced Biotherapeutics, Inc. |
Delaware | |
| Athersys Limited |
United Kingdom | |
| ReGenesys LLC |
Delaware | |
| ReGenesys BVBA |
Belgium | |
| Oculus Pharmaceuticals, Inc. (50% ownership)(1) |
Delaware | |
| (1) | Liquidation of Oculus approved by its stockholders in January 2012. Asset distribution was insignificant. |